Evidence map›Paper›PMID 38850267›Full record

ArticleMicrobial biotechnology2024

Contribution of MALDI-TOF mass spectrometry and machine learning including deep learning techniques for the detection of virulence factors of Clostridioides difficile strains.

Alexandre Godmer, Quentin Giai Gianetto, Killian Le Neindre, Valentine Latapy, Mathilda Bastide, Muriel Ehmig, Valérie Lalande, Nicolas Veziris, Alexandra Aubry, Frédéric Barbut and 1 more

Abstract read
In one paragraph

Article in Microbial biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Interpretable machine learning of clinical MALDI-TOF spectra discriminates carbapenem-resistantJournal of mass spectrometry and advances in the clinical lab · 2025
    Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Alexandre GodmerU1135, Centre d'Immunologie et Des Maladies Infectieuses (Cimi-Paris), Sorbonne Université, Paris, France.ORCID 0000-0002-5211-5796
Quentin Giai GianettoInstitut Pasteur, Université Paris Cité, Bioinformatics and Biostatistics HUB, Paris, France.
Killian Le NeindreAP-HP, Sorbonne Université (Assistance Publique Hôpitaux de Paris), National Reference Laboratory for Clostridioides Difficile, Paris, France.
Valentine LatapyDépartement de Bactériologie, AP-HP, Sorbonne Université (Assistance Publique Hôpitaux de Paris), Groupe Hospitalier Universitaire, Sorbonne Université, Hôpital, Saint-Antoine, Paris, France.
Mathilda BastideDépartement de Bactériologie, AP-HP, Sorbonne Université (Assistance Publique Hôpitaux de Paris), Groupe Hospitalier Universitaire, Sorbonne Université, Hôpital, Saint-Antoine, Paris, France.
Muriel EhmigAP-HP, Sorbonne Université (Assistance Publique Hôpitaux de Paris), National Reference Laboratory for Clostridioides Difficile, Paris, France.
Valérie LalandeDépartement de Bactériologie, AP-HP, Sorbonne Université (Assistance Publique Hôpitaux de Paris), Groupe Hospitalier Universitaire, Sorbonne Université, Hôpital, Saint-Antoine, Paris, France.
Nicolas VezirisU1135, Centre d'Immunologie et Des Maladies Infectieuses (Cimi-Paris), Sorbonne Université, Paris, France.
Alexandra AubryU1135, Centre d'Immunologie et Des Maladies Infectieuses (Cimi-Paris), Sorbonne Université, Paris, France.
Frédéric BarbutAP-HP, Sorbonne Université (Assistance Publique Hôpitaux de Paris), National Reference Laboratory for Clostridioides Difficile, Paris, France.
Catherine EckertU1135, Centre d'Immunologie et Des Maladies Infectieuses (Cimi-Paris), Sorbonne Université, Paris, France.

Funding

Santé Publique France (Public Health France)
6 · The paper itself

Abstract

Clostridioides difficile (CD) infections are defined by toxins A (TcdA) and B (TcdB) along with the binary toxin (CDT). The emergence of the 'hypervirulent' (Hv) strain PR 027, along with PR 176 and 181, two decades ago, reshaped CD infection epidemiology in Europe. This study assessed MALDI-TOF mass spectrometry (MALDI-TOF MS) combined with machine learning (ML) and Deep Learning (DL) to identify toxigenic strains (producing TcdA, TcdB with or without CDT) and Hv strains. In total, 201 CD strains were analysed, comprising 151 toxigenic (24 ToxA

Indexed as

Clostridioides difficileSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationVirulence FactorsBacterial ProteinsBacterial ToxinsClostridium InfectionsDeep LearningEnterotoxinsHumansMachine LearningSensitivity and SpecificityBacterial ProteinsBacterial ToxinsEnterotoxinstoxB protein, Clostridium difficileVirulence Factors

Identifiers

PMID38850267
PMCPMC11162102

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.